However, SUMOylation inhibits a protective effect of ERK5 in diabetes (108), as small ubiquitin-like modifier (SUMO) covalently attaches to certain residues of specific target proteins and negatively regulates transcription factors (109,110). Here, MAPK7 is linked to diabetes mellitus.